Merck Chided By AARP, Democrats Over Drug Price Suit

By Theresa Schliep · September 19, 2023, 9:13 PM EDT

The AARP, along with Democratic lawmakers and physician groups, lambasted Merck & Co. Inc.'s challenge to the Medicare drug price negotiation program on Tuesday, disputing the pharmaceutical company's constitutional arguments and...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

MERCK & CO., INC. v. BECERRA et al

Case Number

Court

District Of Columbia

Nature of Suit

Civil Rights: Other

Date Filed

June 06, 2023

Recent Articles By Theresa

July 23, 2024
Kickback Risk Remains For Gene Therapy Fertility Programs
July 16, 2024
No Let-Up On DOJ Medicare Advantage Fraud Probes
July 09, 2024
Jarkesy Decision May Hit Key Healthcare Enforcement Tool
July 02, 2024
4 Takeaways From FDA's Clinical Trial Diversity Guidance
June 28, 2024
Health Regulators Likely To Tread Carefully Post-Chevron
June 25, 2024
Mich. Judge Blocks State Abortion Waiting Period, Counseling
June 25, 2024
In High Court Loss, Anti-Abortion Atty Sees Win For Objectors
June 18, 2024
Prelogar's Mifepristone Win Is 'A Master Class,' Advocates Say
June 13, 2024
Abortion Medication Case Ends 'With A Whimper' At High Court
June 04, 2024
HHS Guidance, Feud Over FCA Evidence, And A Deposed AG